Preveceutical Medical Inc C.PREV

Alternate Symbol(s): PRVCF

Healthcare Biotechnology

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).

CSE:PREV - Post by User

Preveceutical Medical Inc

Bullboard Posts

Comment by CanadaCoinon Apr 04, 2019 6:05pm

83 Views

Post# 29584683

RE:RE:RE:RE:Big news for PREV

I guess you do not know how to read. PREV has 20% interest in the Asterion biotech Joint Venture, but 0% in Asterion’s Australia’s cannabis operation!

Geez!

DD34 wrote: You must have missed this part in the Sept 26th NR that you quoted earlier. Guess you didnt read all the way down?

"Under the terms of the development agreement, any cash requirements by the joint venture for the development of medicinal cannabis products will be financed 100 per cent by Asterion, at cost. Asterion will also be contributing its management's industry knowledge and contacts to the joint venture, while Preveceutical will be providing access to its research team and the resources at its disposal. Any intellectual property and products developed by the joint venture during its term will be owned by Asterion and Preveceutical jointly on a split ratio, as to 80 per cent Asterion and as to 20 per cent Preveceutical. Any intellectual property developed by the joint venture will be controlled exclusively by Asterion. The development agreement has an initial term of two years, renewable by the parties for an additional two-year term. Preveceutical will receive 20 per cent of the net revenue earned or proceeds received by the joint venture from the sale of the intellectual property and products developed by the joint venture."

https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aPREV-2663291&symbol=PREV&region=C

CanadaCoin wrote:

opsd1 wrote:

Vancouverbound wrote: Buying into PREV now after the Gault will be like buying Canopy when they started trading in the open market.... This will be HUGE!

From another board on the Internet...

Prev looks to make a potential 20% of a billion dollars a year which puts their stock price at around $2.00. yup $2.00 !!! It is estimated that annual production from the asterion Facility will be approximately 500,000 kg of medicinal cannabis product, having an export value in excess of $1 billion, with approximately 20,000 plants harvested per day.

Where on earth does PREV get that 20% from?